Introduction
Marijuana, the plant that has attracted attention for its medicinal uses is still the subject of research. Well known for its variety of its chemicals such as cannabinoids, cannabis is extensively studied and gaining much interest especially in the medical area. Even today most of its operations are considered to be controversial, but organizations such as the U.S. Food and Drug Administration (FDA) hold the key to the future of these technologies.
Cannabis and Its Components
The mixture that can be found in cannabis is more than eighty in number known as cannabinoids where THC and CBD are the popular ones. THC is known to produce psychoactive effects, while CBD has come under strong focus because of its ability to produce numerous medical benefits without producing any high feeling.
Only a few products have been approved by the FDA and these are meant for certain ailments, namely, Epidiolex which is a pure CBD substance approved for some epilepsy cases, synthetic drugs like, Marinol, and Cesamet useful in handling nausea and loss of appetite among cancer patients and AIDS patients respectively. However, the agency has not endorsed whole plant cannabis in their crude state for treating any disease.
FDA’s Role in Research and Approval
An additional aspect concerning the FDA system of drug approval is to guarantee that the cannabis-based medicines satisfy the highest levels of safety and efficacy. Before treatment with a new drug can be approved, the clinical trials must offer scientific evidence. This keeps the patient from getting exposed to several risks with products that have not been approved by regulatory agencies.
Better still, the FDA is helpful to researchers in providing information to conduct studies with marijuana based products through providing guidelines on how to go about the same. This includes assisting researchers on issues like, where to go to get IND approvals or what the law says. It’s also important to note that legal developments like the 2018 Farm Bill have also made research into hemp – a form of cannabis with low THC content – easier.
Challenges and Opportunities
Cannabis has been latterly legal but the majority of its products are not approved by the FDA therefore consumers remain in the dark about the safety and efficacy of cannabis products. It is not safe for consumers to buy unapproved products since they can be of differing strengths, may be impure, and may not have been labeled correctly. Nevertheless, with the help of researches and programs such as FDA’s ‘Fast Track’ and ‘Breakthrough Therapy’ designations progress on developing safe and effective cannabinoid-based medicines remains to be made.
The Bottom Line
The medical use of cannabis is evident however moving from plant to production of medicine requires research and probably legal frameworks. The FDA serves a very important function in making sure that products from the cannabis plant are safe and any treatments are effective. Through promoting high standards research and encouraging scholars or medical companies to come up with intelligent and scientific approaches to Cannabidiol treatments, the FDA not only stimulates the innovative development of the scope of healthcare but also ensures the hey-blend safety of the consumptive products to people.
Are you passionate about cannabis research and innovation? Contribute your insights to the Cannabis Write For Us Guest Post section and be a part of the conversation!
0 Comments